We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...

Q4 2024 Earnings Call Transcript February 11, 2025 Royalty Pharma plc misses on earnings expectations. Reported EPS is ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

As per Intent Market Research, the Cell Analysis Market was valued at USD 19.2 billion in 2023-e and will surpass USD 38.4 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.